Science ❯ Biotechnology ❯ Genetics

Gene Therapy

Duchenne Muscular Dystrophy Clinical Trials Adeno-Associated Virus (AAV) Personalized Medicine Lipid Nanoparticles Rare Diseases Sickle Cell Disease CRISPR Technology SIRT6 Gene Ethical Implications

Vertex Projects Casgevy Sales Above $100 Million in 2025 as CRISPR Therapeutics Waits for Payoff

Casgevy’s months-long, center-based treatment model is slowing early sales.